![Jian Irish](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jian Irish
Amministratore Delegato presso
METAGENOMI THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Jian Irish is currently Chief Executive Officer & Director at Metagenomi Therapeutics, Inc. since 2025.
Former positions include Chief Operating Officer at Metagenomi Technologies LLC in 2021, Chief Operating Officer at Affini-T Therapeutics, Inc. from 2021 to 2022, Chief Technology Officer & Director at Fosun Kite Biotechnology Co., Ltd. from 2018 to 2020, Senior Vice President & Global Head-Manufacturing at Kite Pharma, Inc. from 2016 to 2020, Vice President-Biologics Supply & Partnerships at Sanofi from 2015 to 2016, and Executive Director-Contract Manufacturing at Amgen, Inc. from 2000 to 2014.
Education includes graduate and doctorate degrees from Chiba University, an undergraduate degree from East China University of Science & Technology, and an MBA from UCLA Anderson School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 962.960 ( 2,56% ) | 1 M $ | 31/05/2026 |
Posizioni attive di Jian Irish
| Società | Posizione | Inizio |
|---|---|---|
| METAGENOMI THERAPEUTICS, INC. | Amministratore Delegato | 11/11/2025 |
Precedenti posizioni note di Jian Irish
| Società | Posizione | Fine |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Direttore operativo | 01/01/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | 01/12/2020 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
| SANOFI | Corporate Officer/Principal | 01/08/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/09/2014 |
Formazione di Jian Irish
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Chiba University
 Chiba University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops immune cell therapies | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Develops genetic medicines using metagenomics-powered genome editing toolbox | Health Technology |
Metagenomi, Inc.
 Metagenomi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a genetic medicines company that develops curative therapeutics for patients | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops T-cell therapies for cancer patients cancer | Health Technology |
